LEMKEY JOHN G (Chief Financial Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2020ACC: 0001209191-20-010494
Officer· Chief Financial Officer
Since Jun 2018
+86.00
Net shares
Net buyer
$1.1K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
86.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+43.00
Price / share
$26.73
Trade value
$1.15K
% of position
1.9%
2/14/2020
2.32K→2.36K
Total
Net shares
+43.00
Net value
$1.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/14/2020 | A · Award | +43.00 | $26.73 | $1.15K | 1.9% | 2.32K | 2.36K |
| Total | +43.00 | $1.15K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
43.00 shares
Shares
+43.00
Strike price
31.45
Held after
43.00
Exercisable
—
2/14/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock43.00 shares | 2/14/2020 | A · Award | +43.00 | 31.45 | — | 43.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned14.08M
Total
14.08M indirect14.08M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 14.08M | Indirect |
| Total | 14.08M | 14.08M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported